Product Information
OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET is a generic product labeled by KVK-Tech Inc., priced at $0.1825 per EA under NDC 10702018601. Its NADAC has been published 337 times since Sep 11, 2019.
FDA first approved this application on Feb 9, 2018. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Oxycodone and Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
325; 7.5 mg/1; mg/1
Manufacturer
KVK-Tech Inc.NDC
10702018601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; OXYCODONEApproval Type
Generic (ANDA)
FDA Application
ANDA210644FDA Approved
2/9/2018
TE Code
AA
On Market Since
2/9/2018
Pharmacological Classes
Price Statistics
The NADAC for OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has been published 337 times since Sep 11, 2019, and over the history we have for it it has declined 9.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1825 per EA |
|---|---|
| All-time high | $0.2438 (Apr 15, 2020) |
| All-time low | $0.0972 (Jul 21, 2021) |
| 52-week high | $0.1973 |
| 52-week low | $0.1734 |
| Median price | $0.1646 |
| Average price | $0.1643 |
| Largest weekly change | -39.0% (Apr 22, 2020) |
| Weeks tracked | 337 |
| Tracking since | Sep 11, 2019 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, manufactured by KVK-Tech Inc., is $0.1825 per EA (NDC 10702018601), effective Aug 19, 2026.
How has the price of OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has declined 9.0%. It has been tracked across 337 weekly CMS publications since Sep 11, 2019.
What are the highest and lowest recorded NADAC prices for OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
Since Sep 11, 2019, the NADAC for OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has ranged from a low of $0.0972 (Jul 21, 2021) to a high of $0.2438 (Apr 15, 2020), with a median of $0.1646 per EA.
Are there cheaper alternatives to OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, is $0.1272 per EA — about 30% below OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET.
Who manufactures OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET (NDC 10702018601) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.